ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,405Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 973

$547K Total Retail Price of All Prescriptions

Rank: 109 out of 973

525 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 525 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 525 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 8,503 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LISINOPRIL 522 415 1 3
LEVOTHYROXINE SODIUM 383 295 2 2
METFORMIN HCL 359 236 3 8
SIMVASTATIN 306 242 4 1
AMLODIPINE BESYLATE 290 250 5 7
PRAVASTATIN SODIUM 290 234 5 22
HYDROCODONE-ACETAMINOPHEN 288 188 S3 7 4
OMEPRAZOLE 274 200 8 5
FUROSEMIDE 250 188 9 6
TRAMADOL HCL 227 145 10 18
METOPROLOL SUCCINATE 205 185 11 17
GABAPENTIN 189 94 12 12
LOVASTATIN 187 145 13 38
POTASSIUM CHLORIDE 174 135 14 9
TAMSULOSIN HCL 165 160 15 28
HYDROCHLOROTHIAZIDE 165 125 15 11
ATORVASTATIN CALCIUM 161 112 17 15
CYCLOBENZAPRINE HCL 161 48 R 17 42
LOSARTAN POTASSIUM 152 117 19 19
METOPROLOL TARTRATE 143 110 20 13
FENOFIBRATE 142 130 21 77
ALENDRONATE SODIUM 134 126 22 24
ATENOLOL 119 89 23 16
TRIAMTERENE-HCTZ 119 103 23 51
LISINOPRIL-HYDROCHLOROTHIAZIDE 113 106 25 25
CITALOPRAM HBR 112 59 26 14
MELOXICAM 112 81 26 23
CARVEDILOL 111 94 28 27
GLIMEPIRIDE 104 81 29 41
ALLOPURINOL 103 71 30 29
WARFARIN SODIUM 103 95 30 10
DONEPEZIL HCL 94 90 32 26
GLYBURIDE 93 68 R 33 59
DIGOXIN 93 81 33 32
FLUTICASONE PROPIONATE 90 70 35 35
PANTOPRAZOLE SODIUM 80 54 36 37
DILTIAZEM 24HR CD 80 68 36 104
PEN NEEDLE 79 43 38 171
NAMENDA 73 70 39 31
HYDRALAZINE HCL 71 65 40 157
CRESTOR 71 63 40 34
ACTOS 69 47 42 119
SPIRIVA 69 68 42 73
NAPROXEN 68 49 44 94
VENTOLIN HFA 66 49 45 180
CIPROFLOXACIN HCL 65 54 46 57
PAROXETINE HCL 64 63 47 66
KLOR-CON M20 64 55 47 64
SERTRALINE HCL 62 42 49 21
GLYBURIDE-METFORMIN HCL 62 53 R 49 193
FLUOXETINE HCL 61 35 51 56
LANTUS SOLOSTAR 59 37 52 99
PREDNISONE 59 41 52 33
CLOPIDOGREL 55 39 54 44
JANUVIA 54 28 55 88
OXYCODONE HCL 53 12 S2 56 79
ADVAIR DISKUS 50 19 57 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.